Profile
Zuxu Yao worked as an Associate Director of Research & Development at Adnavance Technologies, Inc. from 2008 to 2009.
He then worked as the Vice President of Assay Development at Nexogen, Inc. from 2012 to 2014.
From 2014 to 2023, he served as the Chief Technical Officer at DermTech, Inc. Dr. Yao holds a doctorate degree from Memorial University of Newfoundland.
Former positions of Zuxu Yao
| Companies | Position | End |
|---|---|---|
| DERMTECH, INC. | Chief Tech/Sci/R&D Officer | 31/12/2022 |
| Nexogen, Inc. | Corporate Officer/Principal | 31/07/2014 |
Adnavance Technologies, Inc.
 Adnavance Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Adnavance is a molecular diagnostic company focused on development of DNA-based tests using the Company's patented metalized DNA (M-DNA) platform. The Company is headquartered in Vancouver, British Columbia and also maintains a DNA development laboratory in San Diego, CA. M-DNA is based on the conducting properties of hybridized DNA. Under strict reaction conditions, certain metal ions can enter the central core of hybridized DNA and displace the hydrogen bonds forming the equivalent of a metal wire in the center of the DNA and making the DNA highly conductive. The Company uses a microarray of 10-micron electrodes to detect the M-DNA and the inherent ultra-sensitivity arises from the differential change in conductivity between hybridized DNA and metalized DNA. This change in conductivity is so large that it obviates the need for target amplification used in current molecular-based tests. Adnavance scientists were the first to discover the M-DNA phenomenon, and the Company believes its technology platform will open new molecular testing markets. | Corporate Officer/Principal | 30/11/2009 |
Training of Zuxu Yao
| Memorial University of Newfoundland | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DERMTECH, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Adnavance Technologies, Inc.
Adnavance Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Adnavance is a molecular diagnostic company focused on development of DNA-based tests using the Company's patented metalized DNA (M-DNA) platform. The Company is headquartered in Vancouver, British Columbia and also maintains a DNA development laboratory in San Diego, CA. M-DNA is based on the conducting properties of hybridized DNA. Under strict reaction conditions, certain metal ions can enter the central core of hybridized DNA and displace the hydrogen bonds forming the equivalent of a metal wire in the center of the DNA and making the DNA highly conductive. The Company uses a microarray of 10-micron electrodes to detect the M-DNA and the inherent ultra-sensitivity arises from the differential change in conductivity between hybridized DNA and metalized DNA. This change in conductivity is so large that it obviates the need for target amplification used in current molecular-based tests. Adnavance scientists were the first to discover the M-DNA phenomenon, and the Company believes its technology platform will open new molecular testing markets. | Commercial Services |
| Nexogen, Inc. |
- Stock Market
- Insiders
- Zuxu Yao
